Richard Sykes (biochemist)

Richard Sykes
Born	Richard Brook Sykes (1942-08-07) 7 August 1942 (age 74)
Fields	Microbiology Antibiotics β-Lactam
Institutions	Imperial College London Imperial College Healthcare Glaxo Wellcome Squibb Institute for Medical Research Natural History Museum, London Royal Botanic Gardens, Kew NHS London Brunel University Eurasian Natural Resources Corporation Reform think tank
Alma mater	Queen Elizabeth College (BSc) University of Bristol (PhD) Brunel University (DSc)
Thesis	Studies on the B-lactamases of Pseudomonas aeruginosa (1972)
Known for	Aztreonam Attempted merger of UCL and Imperial
Notable awards	FRS (1997) Knight Bachelor (1994) FMedSci HonFREng (1942)

Sir Richard Brook Sykes, DSc, FRS, FMedSci, HonFREng (born 7 August 1942) is chairman of the Royal Institution,Imperial College Healthcare and Chancellor of Brunel University. Sykes also chairs the UK Stem Cell Foundation and is Non-executive director of Lonza AG.

Sykes was educated at Queen Elizabeth College where he graduated with a Bachelor of Science degree in Microbiology. He went on to study for a PhD in Microbial Biochemistry at the University of Bristol, graduating in 1972 with thesis on B-lactamases of Pseudomonas aeruginosa.

Until 2002, Sir Richard Sykes was chairman of GlaxoSmithKline, following a research career in Glaxo and Glaxo Wellcome. He was rector of Imperial College London, UK, from 2001-2008. In October 2008, Sykes accepted Farad Azima's invitation to join the NetScientific Group as the non-executive Chairman. Sir Richard was the Senior Independent Director and non-executive Deputy Chairman and Chairman of the Remuneration Committee of Eurasian Natural Resources Corporation (ENRC) until June 2011.

Between January 2001 and July 2008, Sykes was the Rector of Imperial College London.

...
Wikipedia